Hot Stock Analyst

  • Home
  • About
  • Blog
  • Market Conditions
Menu
November 16, 2020 Investing and Market Analysis No Comments

2 Pharma Stocks To Consider Picking Up On The Dip

“We all love to buy pharma stocks when they release positive clinical data, but they can also be solid choices for investors looking for businesses to buy on the dip,” […]

read more
April 24, 2020 Investing and Market Analysis No Comments

3 Biotech/Pharma Stocks With Potential Clinical Trial Catalysts This Quarter

“In light of the ongoing COVID-19 pandemic, a number of pharma companies have postponed new study starts and have paused enrollment/screening in their clinical trials. However, companies that have completed […]

read more
February 14, 2020 Investing and Market Analysis No Comments

The Pharmaceutical Companies Experiencing Early Success With These “Miracle” Cancer Drugs

One of the most significant – and relatively recent – innovations in the treatment of cancer are so-called immuno-oncology (IO) drugs. As today’s article explains, these drugs “enlist a patient’s […]

read more
January 13, 2020 Investing and Market Analysis No Comments

20 Biotech And Pharma Stocks Offering More-Than-Your-Average Upside Potential

More than 10 years into this bull market, Buy and Outperform analyst ratings generally come with implied upside potential of 8% to 10%. However, the author of today’s article notes […]

read more
October 18, 2017 Investing and Market Analysis, Uncategorized No Comments

This Little-Known Biotech Is Attracting The Attention Of Big Pharma – And Creating An Opportunity For Investors

With only 10% of drug candidates that reach the clinical trial stage eventually making their way onto the market, knowing which small biotechs to bet on for big gains is […]

read more

Free Report

Archives

Legals

  • DATA USE POLICY
  • TERMS OF USE
  • Disclaimer
  • PRIVACY POLICY
  • Contact US

Legals

  • DATA USE POLICY
  • TERMS OF USE
  • Disclaimer
  • PRIVACY POLICY
  • Contact US

Free Report

Hot Stock Analyst – Financial Newsletters, Stock Research and More